Short Information | Oncocyte Corporation (NYSE:OCX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 673,223 |
Total Actual Volume | 29,099,775 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 33,661 |
Average Short Percentage | 2.32% |
Is there a OCX Short Squeeze or Breakout about to happen?
See the OCX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
03-19-2021 | $4.58 | $4.805 | $5 | $4.55 | 2,265,701 | 31,967 | 1.41% |
03-18-2021 | $4.81 | $4.53 | $4.92 | $4.5 | 728,026 | 9,151 | 1.26% |
03-05-2021 | $3.91 | $3.72 | $4.1 | $3.01 | 2,943,556 | 96,091 | 3.26% |
03-04-2021 | $4.6 | $3.9 | $4.6131 | $3.77 | 1,369,389 | 52,535 | 3.84% |
03-03-2021 | $4.66 | $4.33 | $4.78 | $4.24 | 1,126,697 | 17,708 | 1.57% |
03-02-2021 | $4.97 | $4.55 | $5.13 | $4.47 | 2,720,099 | 16,394 | 0.6% |
03-01-2021 | $5.13 | $4.88 | $5.24 | $4.87 | 1,267,579 | 10,623 | 0.84% |
02-26-2021 | $5.24 | $4.92 | $5.59 | $4.92 | 948,246 | 20,235 | 2.13% |
02-25-2021 | $5.6 | $5.34 | $5.8 | $5.23 | 791,594 | 22,374 | 2.83% |
02-24-2021 | $5.8 | $5.86 | $6.21 | $5.7173 | 537,357 | 15,984 | 2.97% |
02-23-2021 | $5.6 | $5.79 | $5.9238 | $5.23 | 1,422,454 | 32,419 | 2.28% |
02-22-2021 | $6.39 | $6.19 | $6.5 | $5.96 | 1,302,089 | 28,636 | 2.2% |
02-19-2021 | $5.55 | $6.34 | $6.5 | $5.55 | 1,124,516 | 9,132 | 0.81% |
02-18-2021 | $6.1 | $6.19 | $6.2917 | $5.6106 | 915,270 | 20,923 | 2.29% |
02-17-2021 | $6.49 | $6.37 | $6.49 | $6.2 | 923,566 | 12,924 | 1.4% |
02-16-2021 | $6.07 | $6.5 | $6.53 | $5.85 | 1,846,570 | 33,495 | 1.81% |
02-12-2021 | $5.69 | $5.92 | $5.97 | $5.51 | 984,455 | 45,109 | 4.58% |
02-11-2021 | $6.01 | $5.75 | $6.05 | $5.4 | 1,365,180 | 40,045 | 2.93% |
02-10-2021 | $6.45 | $5.85 | $6.57 | $5.35 | 2,573,168 | 61,279 | 2.38% |
02-09-2021 | $5.91 | $5.56 | $5.96 | $5.46 | 1,944,263 | 96,199 | 4.95% |
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView, a leader within the financial markets and news community, announces the release of an article highlighting the precision diagnostics company, Oncocyte’s (Nasdaq: OCX) appointment of leading finance executive, Andrea Jame...
IRVINE, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that it has appointed leading finance executive, Andrea James, to the position of Chief Financial Officer. “We are thrilled to welcome Andrea...
(NewsDirect) Chronic conditions such as organ transplant rejection and cancer represent significant challenges in modern healthcare, demanding precise diagnostic tools for effective management and treatment. For organ transplant patients, the risk of graft rejection remains a persistent threa...